VF

Varishali Faijulhusain Sunsara

Director Director DIN 03436220
DIN 03436220 First appointment Mar 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2011
Shareholding value •••• Premium profile

About Varishali Faijulhusain Sunsara

Data last updated:

Varishali Faijulhusain Sunsara was a Director at Lustre Pharmaceuticals Private Limited (2011–2012) and Director at Hotel Sifat International Private Limited (2013–2017). The companies operate in Pharma and Travel and Hospitality.

DIN 03436220
Primary Designation Director
Industry Pharma
First Appointment 01 Mar 2011

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Mar 20112003₹10.03 Cr (FY 2025)Active
Director20 Sep 20132013₹42,000 (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lustre Pharmaceuticals Private Limited
Hotel Sifat International Private Limited
Premium access

Shareholding and investment profile for Varishali Faijulhusain Sunsara

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Varishali Faijulhusain Sunsara

Varishali Faijulhusain Sunsara was first appointed on 01 Mar 2011 as Director at Lustre Pharmaceuticals Private Limited. The most recent appointment on record is 20 Sep 2013 at Hotel Sifat International Private Limited.

Varishali Faijulhusain Sunsara held 2 earlier board appointments: Lustre Pharmaceuticals Private Limited (Director, 01 Mar 2011 to 30 Jun 2012); Hotel Sifat International Private Limited (Director, 20 Sep 2013 to 08 Mar 2017).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available